Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983 Dec;54(3):793-800.

The effect of C3 levels on yeast opsonization by normal and pathological sera: identification of a complement independent opsonin

The effect of C3 levels on yeast opsonization by normal and pathological sera: identification of a complement independent opsonin

M A Kerr et al. Clin Exp Immunol. 1983 Dec.

Abstract

The ability of 150 normal and pathological sera to opsonize yeast for uptake by isolated human polymorphonuclear leucocytes has been studied. Phagocytosis was measured by an assay depending on electronic particle counting to measure yeast uptake and by a new fluorometric assay which is able to distinguish particle adherence from true phagocytosis. The opsonic activity of normal human serum was heat labile and depended markedly on C3 levels. The sera of 6% of healthy young adults (three from 45) and 8% of healthy donors aged 65-88 (four from 57) showed defective opsonization in spite of normal C3 and CH50 levels. Thirty-eight pathological sera with low C3 levels showed defective opsonization. However, three sera with low C3 levels showed apparently normal opsonic activity. The opsonin from two of these sera was characterized. It was heat stable, had apparent mol.wt of 400,000 and was active in serum free media. The opsonin was absorbed by immobilized Staphylococcus aureus and by gelatin-Sepharose, suggesting that it is related to fibronectin. Fibronectin from normal human sera prepared by affinity chromatography on gelatin-Sepharose was not opsonic in this system.

PubMed Disclaimer

References

    1. J Immunol. 1971 Dec;107(6):1535-46 - PubMed
    1. Pediatrics. 1972 Aug;50(2):264-70 - PubMed
    1. J Infect Dis. 1972 Sep;126(3):257-76 - PubMed
    1. N Engl J Med. 1974 Mar 28;290(13):717-23 - PubMed
    1. J Immunol Methods. 1974 Aug;5(3):249-52 - PubMed

Publication types

LinkOut - more resources